Legal and Safety Information
Important JUVÉDERM® Treatment Considerations
JUVÉDERM® Ultra and JUVÉDERM® Ultra Plus are indicated for injection into the mid to deep dermis for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds). Side effects were usually mild to moderate lasting 7 days or less and included temporary injection site reactions like redness, pain, firmness, swelling and bumps. For more information, please visit www.juvederm.com or call the Allergan Product Support line at 1-877-345-5372.
Policy
All comments, visuals, videos and any other type of material posted by fans on this site and on their own Facebook sites do not necessarily reflect the opinions or ideas of JUVÉDERM®, Allergan, its employees or affiliates, and Allergan is not responsible for any such content. All material posted must comply with Facebook's Terms of Use. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of JUVÉDERM® and Allergan. ©2009 Allergan, Inc. ® and ™ marks owned by Allergan, Inc. JUVÉDERM® mark owned by Allergan Industrie SAS.
For customer service inquiries please visit us at www.juvederm.com.
From the UK? Visit www.allerganbeauty.co.uk
©2009 Allergan, Inc. ® and ™ marks owned by Allergan, Inc.
JUVÉDERM® mark owned by Allergan Industrie SAS.
MDOC-03522-02


Important JUVÉDERM® Treatment Considerations
*JUVÉDERM® Ultra and JUVÉDERM® Ultra Plus are indicated for injection into the mid to deep dermis for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds). Side effects were usually mild to moderate lasting 7 days or less and included temporary injection site reactions like redness, pain, firmness, swelling and bumps. For more information, please visit www.juvederm.com or call the Allergan Product Support line at 1-877-345-5372.
Policy
All comments, visuals, videos and any other type of material posted by fans on this site and on their own Facebook sites do not necessarily reflect the opinions or ideas of JUVÉDERM®, Allergan, its employees or affiliates, and Allergan is not responsible for any such content. All material posted must comply with Facebook's Terms of Use. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of JUVÉDERM® and Allergan. ©2009 Allergan, Inc. ® and ™ marks owned by Allergan, Inc. JUVÉDERM® mark owned by Allergan Industrie SAS.
For customer service inquiries please visit us at www.juvederm.com.
|
From the UK? Visit www.juvedermultra.co.uk ©2009 Allergan, Inc. ® and ™ marks owned by Allergan, Inc. JUVÉDERM® mark owned by Allergan Industrie SAS. GLX Technology™ is owned by Pharma Cosmetix Research, LLC. MDOC-03748-02 |










